ArticleFrontiers in public health2025
Geotemporal disparities in hip fractures burden among individuals aged ≥55 years (1990-2021) with projections to 2050.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impact of modified ERAS protocol implementation on length of stay and complications in elderly hip fracture patients: a before-and-after study.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026Article
- Early Mobilization Compliance as a Quality Indicator After Hip Fracture Surgery: An Observational Study.Journal of clinical medicine · 2026Article
- Intrinsic capacity trajectory and hip fracture risk in Chinese middle-aged and older adults: a 10-year retrospective cohort study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hip fractures (HFs) are common among older adults and represent a major cause of long-term functional impairment. The lack of up-to-date epidemiological data hinders the development of effective public health policies. This study investigates trends in HFs among individuals aged ≥55 years (HFs (≥55 years)), providing essential evidence to inform future prevention strategies. Methods: Using Global Burden of Disease Study 2021 data, we analyzed the age-standardized incidence rate (ASIR), prevalence rate (ASPR), and years lived with disability (YLDs) rate (ASYR), along with their trends, driving factors, age-sex-time patterns, health outcomes efficiency, and projections up to 2050. Results: In 2021, the global ASIR, ASPR, and ASYR of HFs (≥55 years) were 1,027.46 (95% UI: 719.73-1416.07), 2,037.39 (95% UI: 1,670.75-2475.71) per 100,000, and 185.49 (95% UI: 125.69-259.43) per 100,000 person-years, respectively. From 1990 to 2021, global ASIR and ASPR showed an overall upward trend, whereas ASYR declined (ASIR: AAPC = 0.20, 95% CI: 0.12-0.28; ASPR: AAPC = 0.31, 95% CI: 0.27-0.36; ASYR: AAPC = -0.43, 95% CI: -0.50 - -0.36). These trends are expected to persist by 2050, with ASIR reaching 1,102.66 (95% CI: 101.40-2,142.83), ASPR 2,052.14 (95% CI: 141.30-4,112.55) per 100,000, and ASYR declining to 174.43 (95% CI: 0-365.91) per 100,000 person-years. Significant disparities existed across 204 countries and territories. High SDI region bore a greater burden, though their growth rate had slowed, whereas Low SDI region showed a gradual increase from a lower baseline. Health inequalities were more pronounced in High SDI region, which also had the greatest potential for burden reduction. Population growth and aging were the primary drivers of these trends, with falls remaining the predominant cause. Notably, the burden increased more markedly among males. Conclusion: The global burden of HFs (≥55 years) is rising, underscoring the need to account for the complex distribution across populations and regions. Effective, targeted prevention and treatment strategies are essential to mitigating the disease burden and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.